Global Therapeutic Vaccines Market Growth 2025-2031
The global Therapeutic Vaccines market size is predicted to grow from US$ 52540 million in 2025 to US$ 167680 million in 2031; it is expected to grow at a CAGR of 21.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Vaccines Industry Forecast” looks at past sales and reviews total world Therapeutic Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Vaccines sales for 2025 through 2031. With Therapeutic Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Therapeutic Vaccines market?
What factors are driving Therapeutic Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Vaccines market opportunities vary by end market size?
How does Therapeutic Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Vaccines Industry Forecast” looks at past sales and reviews total world Therapeutic Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Vaccines sales for 2025 through 2031. With Therapeutic Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peptide Therapeutic Vaccine
- Cell Therapeutic Vaccine
- Nucleic Acid Therapeutic Vaccine
- Oncotherapy
- Hepatitis B
- Tuberculosis
- Herpes Simplex Virus
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Northeast Biotherapeutics
- Agenus
- Vaccinogen Inc
- CIMAB S.A
- Dendreon
- Corixa
- AVAX Technologies
What is the 10-year outlook for the global Therapeutic Vaccines market?
What factors are driving Therapeutic Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Vaccines market opportunities vary by end market size?
How does Therapeutic Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Vaccines Segment by Type
2.2.1 Peptide Therapeutic Vaccine
2.2.2 Cell Therapeutic Vaccine
2.2.3 Nucleic Acid Therapeutic Vaccine
2.3 Therapeutic Vaccines Sales by Type
2.3.1 Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Vaccines Sale Price by Type (2020-2025)
2.4 Therapeutic Vaccines Segment by Application
2.4.1 Oncotherapy
2.4.2 Hepatitis B
2.4.3 Tuberculosis
2.4.4 Herpes Simplex Virus
2.4.5 Others
2.5 Therapeutic Vaccines Sales by Application
2.5.1 Global Therapeutic Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Vaccines Breakdown Data by Company
3.1.1 Global Therapeutic Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Vaccines Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Vaccines Sale Price by Company
3.4 Key Manufacturers Therapeutic Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Vaccines Product Location Distribution
3.4.2 Players Therapeutic Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Vaccines Sales Growth
4.4 APAC Therapeutic Vaccines Sales Growth
4.5 Europe Therapeutic Vaccines Sales Growth
4.6 Middle East & Africa Therapeutic Vaccines Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Vaccines Sales by Country
5.1.1 Americas Therapeutic Vaccines Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Vaccines Revenue by Country (2020-2025)
5.2 Americas Therapeutic Vaccines Sales by Type (2020-2025)
5.3 Americas Therapeutic Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Vaccines Sales by Region
6.1.1 APAC Therapeutic Vaccines Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Vaccines Revenue by Region (2020-2025)
6.2 APAC Therapeutic Vaccines Sales by Type (2020-2025)
6.3 APAC Therapeutic Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Vaccines by Country
7.1.1 Europe Therapeutic Vaccines Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Vaccines Revenue by Country (2020-2025)
7.2 Europe Therapeutic Vaccines Sales by Type (2020-2025)
7.3 Europe Therapeutic Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Vaccines by Country
8.1.1 Middle East & Africa Therapeutic Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Vaccines
10.3 Manufacturing Process Analysis of Therapeutic Vaccines
10.4 Industry Chain Structure of Therapeutic Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Vaccines Distributors
11.3 Therapeutic Vaccines Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC VACCINES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Vaccines Market Size Forecast by Region
12.1.1 Global Therapeutic Vaccines Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Vaccines Forecast by Type (2026-2031)
12.7 Global Therapeutic Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Northeast Biotherapeutics
13.1.1 Northeast Biotherapeutics Company Information
13.1.2 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
13.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Northeast Biotherapeutics Main Business Overview
13.1.5 Northeast Biotherapeutics Latest Developments
13.2 Agenus
13.2.1 Agenus Company Information
13.2.2 Agenus Therapeutic Vaccines Product Portfolios and Specifications
13.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Agenus Main Business Overview
13.2.5 Agenus Latest Developments
13.3 Vaccinogen Inc
13.3.1 Vaccinogen Inc Company Information
13.3.2 Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
13.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vaccinogen Inc Main Business Overview
13.3.5 Vaccinogen Inc Latest Developments
13.4 CIMAB S.A
13.4.1 CIMAB S.A Company Information
13.4.2 CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
13.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CIMAB S.A Main Business Overview
13.4.5 CIMAB S.A Latest Developments
13.5 Dendreon
13.5.1 Dendreon Company Information
13.5.2 Dendreon Therapeutic Vaccines Product Portfolios and Specifications
13.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dendreon Main Business Overview
13.5.5 Dendreon Latest Developments
13.6 Corixa
13.6.1 Corixa Company Information
13.6.2 Corixa Therapeutic Vaccines Product Portfolios and Specifications
13.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Corixa Main Business Overview
13.6.5 Corixa Latest Developments
13.7 AVAX Technologies
13.7.1 AVAX Technologies Company Information
13.7.2 AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
13.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AVAX Technologies Main Business Overview
13.7.5 AVAX Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Vaccines Segment by Type
2.2.1 Peptide Therapeutic Vaccine
2.2.2 Cell Therapeutic Vaccine
2.2.3 Nucleic Acid Therapeutic Vaccine
2.3 Therapeutic Vaccines Sales by Type
2.3.1 Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Vaccines Sale Price by Type (2020-2025)
2.4 Therapeutic Vaccines Segment by Application
2.4.1 Oncotherapy
2.4.2 Hepatitis B
2.4.3 Tuberculosis
2.4.4 Herpes Simplex Virus
2.4.5 Others
2.5 Therapeutic Vaccines Sales by Application
2.5.1 Global Therapeutic Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Vaccines Breakdown Data by Company
3.1.1 Global Therapeutic Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Vaccines Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Vaccines Sale Price by Company
3.4 Key Manufacturers Therapeutic Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Vaccines Product Location Distribution
3.4.2 Players Therapeutic Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Vaccines Sales Growth
4.4 APAC Therapeutic Vaccines Sales Growth
4.5 Europe Therapeutic Vaccines Sales Growth
4.6 Middle East & Africa Therapeutic Vaccines Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Vaccines Sales by Country
5.1.1 Americas Therapeutic Vaccines Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Vaccines Revenue by Country (2020-2025)
5.2 Americas Therapeutic Vaccines Sales by Type (2020-2025)
5.3 Americas Therapeutic Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Vaccines Sales by Region
6.1.1 APAC Therapeutic Vaccines Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Vaccines Revenue by Region (2020-2025)
6.2 APAC Therapeutic Vaccines Sales by Type (2020-2025)
6.3 APAC Therapeutic Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Vaccines by Country
7.1.1 Europe Therapeutic Vaccines Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Vaccines Revenue by Country (2020-2025)
7.2 Europe Therapeutic Vaccines Sales by Type (2020-2025)
7.3 Europe Therapeutic Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Vaccines by Country
8.1.1 Middle East & Africa Therapeutic Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Vaccines
10.3 Manufacturing Process Analysis of Therapeutic Vaccines
10.4 Industry Chain Structure of Therapeutic Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Vaccines Distributors
11.3 Therapeutic Vaccines Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC VACCINES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Vaccines Market Size Forecast by Region
12.1.1 Global Therapeutic Vaccines Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Vaccines Forecast by Type (2026-2031)
12.7 Global Therapeutic Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Northeast Biotherapeutics
13.1.1 Northeast Biotherapeutics Company Information
13.1.2 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
13.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Northeast Biotherapeutics Main Business Overview
13.1.5 Northeast Biotherapeutics Latest Developments
13.2 Agenus
13.2.1 Agenus Company Information
13.2.2 Agenus Therapeutic Vaccines Product Portfolios and Specifications
13.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Agenus Main Business Overview
13.2.5 Agenus Latest Developments
13.3 Vaccinogen Inc
13.3.1 Vaccinogen Inc Company Information
13.3.2 Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
13.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vaccinogen Inc Main Business Overview
13.3.5 Vaccinogen Inc Latest Developments
13.4 CIMAB S.A
13.4.1 CIMAB S.A Company Information
13.4.2 CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
13.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CIMAB S.A Main Business Overview
13.4.5 CIMAB S.A Latest Developments
13.5 Dendreon
13.5.1 Dendreon Company Information
13.5.2 Dendreon Therapeutic Vaccines Product Portfolios and Specifications
13.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dendreon Main Business Overview
13.5.5 Dendreon Latest Developments
13.6 Corixa
13.6.1 Corixa Company Information
13.6.2 Corixa Therapeutic Vaccines Product Portfolios and Specifications
13.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Corixa Main Business Overview
13.6.5 Corixa Latest Developments
13.7 AVAX Technologies
13.7.1 AVAX Technologies Company Information
13.7.2 AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
13.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AVAX Technologies Main Business Overview
13.7.5 AVAX Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Therapeutic Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peptide Therapeutic Vaccine
Table 4. Major Players of Cell Therapeutic Vaccine
Table 5. Major Players of Nucleic Acid Therapeutic Vaccine
Table 6. Global Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global Therapeutic Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global Therapeutic Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Therapeutic Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Therapeutic Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Therapeutic Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Therapeutic Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Therapeutic Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Therapeutic Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Therapeutic Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Therapeutic Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Therapeutic Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Therapeutic Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Therapeutic Vaccines Producing Area Distribution and Sales Area
Table 22. Players Therapeutic Vaccines Products Offered
Table 23. Therapeutic Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Therapeutic Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Therapeutic Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Therapeutic Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Therapeutic Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Therapeutic Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Therapeutic Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Therapeutic Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Therapeutic Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Therapeutic Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Therapeutic Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Therapeutic Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Therapeutic Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Therapeutic Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Therapeutic Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Therapeutic Vaccines
Table 53. Key Market Challenges & Risks of Therapeutic Vaccines
Table 54. Key Industry Trends of Therapeutic Vaccines
Table 55. Therapeutic Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Therapeutic Vaccines Distributors List
Table 58. Therapeutic Vaccines Customer List
Table 59. Global Therapeutic Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Therapeutic Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Therapeutic Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Therapeutic Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Therapeutic Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Therapeutic Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Therapeutic Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Therapeutic Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Therapeutic Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Therapeutic Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Therapeutic Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Northeast Biotherapeutics Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
Table 75. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Northeast Biotherapeutics Main Business
Table 77. Northeast Biotherapeutics Latest Developments
Table 78. Agenus Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Agenus Therapeutic Vaccines Product Portfolios and Specifications
Table 80. Agenus Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Agenus Main Business
Table 82. Agenus Latest Developments
Table 83. Vaccinogen Inc Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
Table 85. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Vaccinogen Inc Main Business
Table 87. Vaccinogen Inc Latest Developments
Table 88. CIMAB S.A Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
Table 90. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. CIMAB S.A Main Business
Table 92. CIMAB S.A Latest Developments
Table 93. Dendreon Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Dendreon Therapeutic Vaccines Product Portfolios and Specifications
Table 95. Dendreon Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Dendreon Main Business
Table 97. Dendreon Latest Developments
Table 98. Corixa Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Corixa Therapeutic Vaccines Product Portfolios and Specifications
Table 100. Corixa Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Corixa Main Business
Table 102. Corixa Latest Developments
Table 103. AVAX Technologies Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
Table 105. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. AVAX Technologies Main Business
Table 107. AVAX Technologies Latest Developments
Table 1. Therapeutic Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Therapeutic Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peptide Therapeutic Vaccine
Table 4. Major Players of Cell Therapeutic Vaccine
Table 5. Major Players of Nucleic Acid Therapeutic Vaccine
Table 6. Global Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global Therapeutic Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global Therapeutic Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Therapeutic Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Therapeutic Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Therapeutic Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Therapeutic Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Therapeutic Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Therapeutic Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Therapeutic Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Therapeutic Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Therapeutic Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Therapeutic Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Therapeutic Vaccines Producing Area Distribution and Sales Area
Table 22. Players Therapeutic Vaccines Products Offered
Table 23. Therapeutic Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Therapeutic Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Therapeutic Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Therapeutic Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Therapeutic Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Therapeutic Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Therapeutic Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Therapeutic Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Therapeutic Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Therapeutic Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Therapeutic Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Therapeutic Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Therapeutic Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Therapeutic Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Therapeutic Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Therapeutic Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Therapeutic Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Therapeutic Vaccines
Table 53. Key Market Challenges & Risks of Therapeutic Vaccines
Table 54. Key Industry Trends of Therapeutic Vaccines
Table 55. Therapeutic Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Therapeutic Vaccines Distributors List
Table 58. Therapeutic Vaccines Customer List
Table 59. Global Therapeutic Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Therapeutic Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Therapeutic Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Therapeutic Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Therapeutic Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Therapeutic Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Therapeutic Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Therapeutic Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Therapeutic Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Therapeutic Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Therapeutic Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Therapeutic Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Northeast Biotherapeutics Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
Table 75. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Northeast Biotherapeutics Main Business
Table 77. Northeast Biotherapeutics Latest Developments
Table 78. Agenus Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Agenus Therapeutic Vaccines Product Portfolios and Specifications
Table 80. Agenus Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Agenus Main Business
Table 82. Agenus Latest Developments
Table 83. Vaccinogen Inc Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
Table 85. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Vaccinogen Inc Main Business
Table 87. Vaccinogen Inc Latest Developments
Table 88. CIMAB S.A Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
Table 90. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. CIMAB S.A Main Business
Table 92. CIMAB S.A Latest Developments
Table 93. Dendreon Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Dendreon Therapeutic Vaccines Product Portfolios and Specifications
Table 95. Dendreon Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Dendreon Main Business
Table 97. Dendreon Latest Developments
Table 98. Corixa Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Corixa Therapeutic Vaccines Product Portfolios and Specifications
Table 100. Corixa Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Corixa Main Business
Table 102. Corixa Latest Developments
Table 103. AVAX Technologies Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
Table 105. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. AVAX Technologies Main Business
Table 107. AVAX Technologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Therapeutic Vaccines
Figure 2. Therapeutic Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Therapeutic Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Therapeutic Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Therapeutic Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Therapeutic Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Peptide Therapeutic Vaccine
Figure 12. Product Picture of Cell Therapeutic Vaccine
Figure 13. Product Picture of Nucleic Acid Therapeutic Vaccine
Figure 14. Global Therapeutic Vaccines Sales Market Share by Type in 2025
Figure 15. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. Therapeutic Vaccines Consumed in Oncotherapy
Figure 17. Global Therapeutic Vaccines Market: Oncotherapy (2020-2025) & (K Units)
Figure 18. Therapeutic Vaccines Consumed in Hepatitis B
Figure 19. Global Therapeutic Vaccines Market: Hepatitis B (2020-2025) & (K Units)
Figure 20. Therapeutic Vaccines Consumed in Tuberculosis
Figure 21. Global Therapeutic Vaccines Market: Tuberculosis (2020-2025) & (K Units)
Figure 22. Therapeutic Vaccines Consumed in Herpes Simplex Virus
Figure 23. Global Therapeutic Vaccines Market: Herpes Simplex Virus (2020-2025) & (K Units)
Figure 24. Therapeutic Vaccines Consumed in Others
Figure 25. Global Therapeutic Vaccines Market: Others (2020-2025) & (K Units)
Figure 26. Global Therapeutic Vaccines Sale Market Share by Application (2024)
Figure 27. Global Therapeutic Vaccines Revenue Market Share by Application in 2025
Figure 28. Therapeutic Vaccines Sales by Company in 2025 (K Units)
Figure 29. Global Therapeutic Vaccines Sales Market Share by Company in 2025
Figure 30. Therapeutic Vaccines Revenue by Company in 2025 ($ millions)
Figure 31. Global Therapeutic Vaccines Revenue Market Share by Company in 2025
Figure 32. Global Therapeutic Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Therapeutic Vaccines Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 35. Americas Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 36. APAC Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 37. APAC Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Europe Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 39. Europe Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 42. Americas Therapeutic Vaccines Sales Market Share by Country in 2025
Figure 43. Americas Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Figure 44. Americas Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 45. Americas Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 46. United States Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Therapeutic Vaccines Sales Market Share by Region in 2025
Figure 51. APAC Therapeutic Vaccines Revenue Market Share by Region (2020-2025)
Figure 52. APAC Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 53. APAC Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 54. China Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. India Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Therapeutic Vaccines Sales Market Share by Country in 2025
Figure 62. Europe Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Figure 63. Europe Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 64. Europe Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 65. Germany Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. France Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Egypt Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Therapeutic Vaccines in 2025
Figure 79. Manufacturing Process Analysis of Therapeutic Vaccines
Figure 80. Industry Chain Structure of Therapeutic Vaccines
Figure 81. Channels of Distribution
Figure 82. Global Therapeutic Vaccines Sales Market Forecast by Region (2026-2031)
Figure 83. Global Therapeutic Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Therapeutic Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Therapeutic Vaccines
Figure 2. Therapeutic Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Therapeutic Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Therapeutic Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Therapeutic Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Therapeutic Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Peptide Therapeutic Vaccine
Figure 12. Product Picture of Cell Therapeutic Vaccine
Figure 13. Product Picture of Nucleic Acid Therapeutic Vaccine
Figure 14. Global Therapeutic Vaccines Sales Market Share by Type in 2025
Figure 15. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. Therapeutic Vaccines Consumed in Oncotherapy
Figure 17. Global Therapeutic Vaccines Market: Oncotherapy (2020-2025) & (K Units)
Figure 18. Therapeutic Vaccines Consumed in Hepatitis B
Figure 19. Global Therapeutic Vaccines Market: Hepatitis B (2020-2025) & (K Units)
Figure 20. Therapeutic Vaccines Consumed in Tuberculosis
Figure 21. Global Therapeutic Vaccines Market: Tuberculosis (2020-2025) & (K Units)
Figure 22. Therapeutic Vaccines Consumed in Herpes Simplex Virus
Figure 23. Global Therapeutic Vaccines Market: Herpes Simplex Virus (2020-2025) & (K Units)
Figure 24. Therapeutic Vaccines Consumed in Others
Figure 25. Global Therapeutic Vaccines Market: Others (2020-2025) & (K Units)
Figure 26. Global Therapeutic Vaccines Sale Market Share by Application (2024)
Figure 27. Global Therapeutic Vaccines Revenue Market Share by Application in 2025
Figure 28. Therapeutic Vaccines Sales by Company in 2025 (K Units)
Figure 29. Global Therapeutic Vaccines Sales Market Share by Company in 2025
Figure 30. Therapeutic Vaccines Revenue by Company in 2025 ($ millions)
Figure 31. Global Therapeutic Vaccines Revenue Market Share by Company in 2025
Figure 32. Global Therapeutic Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Therapeutic Vaccines Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 35. Americas Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 36. APAC Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 37. APAC Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Europe Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 39. Europe Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Therapeutic Vaccines Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Therapeutic Vaccines Revenue 2020-2025 ($ millions)
Figure 42. Americas Therapeutic Vaccines Sales Market Share by Country in 2025
Figure 43. Americas Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Figure 44. Americas Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 45. Americas Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 46. United States Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Therapeutic Vaccines Sales Market Share by Region in 2025
Figure 51. APAC Therapeutic Vaccines Revenue Market Share by Region (2020-2025)
Figure 52. APAC Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 53. APAC Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 54. China Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. India Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Therapeutic Vaccines Sales Market Share by Country in 2025
Figure 62. Europe Therapeutic Vaccines Revenue Market Share by Country (2020-2025)
Figure 63. Europe Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 64. Europe Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 65. Germany Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. France Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Therapeutic Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Therapeutic Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Egypt Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Therapeutic Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Therapeutic Vaccines in 2025
Figure 79. Manufacturing Process Analysis of Therapeutic Vaccines
Figure 80. Industry Chain Structure of Therapeutic Vaccines
Figure 81. Channels of Distribution
Figure 82. Global Therapeutic Vaccines Sales Market Forecast by Region (2026-2031)
Figure 83. Global Therapeutic Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Therapeutic Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2026-2031)
